Shagun Singh Analyst Performance

Analyst at Royal Bank Of Canada

Shagun Singh is a stock analyst at Royal Bank Of Canada in the medical sector, covering 18 publicly traded companies. Over the past year, Shagun Singh has issued 72 stock ratings, including buy and hold recommendations. While full access to Shagun Singh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Shagun Singh's coverage history, rating activity, and performance tendencies â€” helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 94 Last 1 Years
Buy Recommendations: 73.63% 67 Buy Ratings
Companies Covered: 18 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	73.6%	67 ratings
Hold	26.4%	24 ratings
Sell	0.0%	0 ratings

Out of 91 total stock ratings issued by Shagun Singh at Royal Bank Of Canada, the majority (73.6%) have been Buy recommendations, followed by 26.4% Hold.

Best & Worst Calls

Best Call
000.0%
JNJ
Apr 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
INSP
Feb 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	66.7% of companies on NYSE	12 companies
NASDAQ	33.3% of companies on NASDAQ	6 companies

Shagun Singh, an analyst at Royal Bank Of Canada, currently covers 18 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	100.0%

Shagun Singh of Royal Bank Of Canada specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 7 companies	38.9%
MED PRODUCTS 7 companies	38.9%
MEDICAL INFO SYS 2 companies	11.1%
LARGE CAP PHARMA 1 company	5.6%
MED/DENTAL - SUPP 1 company	5.6%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
TFX Teleflex	5/8/2026	Upgrade	$131.90	$155.00	Outperform
GMED Globus Medical	5/8/2026	Boost Price Target	$78.85	$120.00	Outperform
PODD Insulet	5/7/2026	Lower Price Target	$161.35	$280.00	Outperform
INSP Inspire Medical Systems	5/5/2026	Lower Price Target	$45.91	$45.00	Sector Perform
BSX Boston Scientific	4/23/2026	Lower Price Target	$65.75	$100.00	Outperform
ABT Abbott Laboratories	4/17/2026	Lower Price Target	$95.08	$130.00	Outperform
JNJ Johnson & Johnson	4/15/2026	Reiterated Rating	$240.14	$265.00	Outperform
PODD Insulet	4/14/2026	Reiterated Rating	$197.78	$325.00	Outperform
INSP Inspire Medical Systems	4/14/2026	Reiterated Rating	$54.88	$56.00	Sector Perform
BSX Boston Scientific	3/30/2026	Reiterated Rating	$63.09	$115.00	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
JNJ Johnson & Johnson	3/30/2026	Reiterated Rating	$242.69	$255.00	Outperform
TFX Teleflex	2/27/2026	Boost Price Target	$121.99	$125.00	Sector Perform
INSP Inspire Medical Systems	2/12/2026	Lower Price Target	$60.04	$68.00	Sector Perform
BDX Becton, Dickinson and Company	2/10/2026	Set Price Target	$169.95	$172.00
BDX Becton, Dickinson and Company	2/9/2026	Lower Price Target	$206.26	$172.00	Sector Perform
BSX Boston Scientific	2/5/2026	Lower Price Target	$76.76	$115.00	Outperform
JNJ Johnson & Johnson	2/3/2026	Boost Price Target	$234.67	$255.00	Outperform
INSP Inspire Medical Systems	1/27/2026	Downgrade	$81.25	$90.00	Sector Perform
ABT Abbott Laboratories	1/23/2026	Lower Price Target	$108.64	$135.00	Outperform
PEN Penumbra	1/20/2026	Downgrade	$350.93	$374.00	Sector Perform
TFX Teleflex	12/17/2025	Reiterated Rating	$126.18	$135.00	Sector Perform
TNDM Tandem Diabetes Care	12/17/2025	Reiterated Rating	$22.60	$30.00	Outperform
PEN Penumbra	12/17/2025	Reiterated Rating	$313.01	$355.00	Outperform
OM Outset Medical	12/17/2025	Reiterated Rating	$4.02	$7.00	Sector Perform
JNJ Johnson & Johnson	12/17/2025	Set Price Target	$209.48	$240.00
GMED Globus Medical	12/17/2025	Boost Price Target	$85.80	$100.00	Outperform
BDX Becton, Dickinson and Company	12/17/2025	Boost Price Target	$196.42	$210.00	Sector Perform
ISRG Intuitive Surgical	12/17/2025	Boost Price Target	$554.58	$650.00	Outperform
INSP Inspire Medical Systems	12/17/2025	Boost Price Target	$115.53	$175.00	Outperform
BSX Boston Scientific	12/17/2025	Boost Price Target	$92.93	$130.00	Outperform
JNJ Johnson & Johnson	12/11/2025	Boost Price Target	$206.50	$230.00	Outperform
EW Edwards Lifesciences	12/5/2025	Boost Price Target	$86.50	$100.00	Outperform
PODD Insulet	11/21/2025	Boost Price Target	$312.89	$380.00	Outperform
MDT Medtronic	11/19/2025	Boost Price Target	$100.84	$118.00	Outperform
SYK Stryker	11/14/2025	Reiterated Rating	$372.93	$435.00	Outperform
OM Outset Medical	11/11/2025	Lower Price Target	$6.29	$17.00	Sector Perform
TFX Teleflex	11/7/2025	Lower Price Target	$109.70	$120.00	Sector Perform
BDX Becton, Dickinson and Company	11/7/2025	Lower Price Target	$175.88	$202.00	Sector Perform
PODD Insulet	11/7/2025	Boost Price Target	$319.11	$370.00	Outperform
GMED Globus Medical	11/7/2025	Boost Price Target	$83.43	$92.00	Outperform
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
ZBH Zimmer Biomet	11/6/2025	Lower Price Target	$87.51	$101.00	Outperform
INSP Inspire Medical Systems	11/4/2025	Lower Price Target	$85.03	$125.00	Outperform
EW Edwards Lifesciences	10/31/2025	Boost Price Target	$83.24	$95.00	Outperform
DXCM DexCom	10/31/2025	Lower Price Target	$56.93	$85.00	Outperform
ISRG Intuitive Surgical	10/22/2025	Set Price Target	$540.05	$625.00	Outperform
ABT Abbott Laboratories	10/16/2025	Reiterated Rating	$129.44	$147.00	Outperform
BDX Becton, Dickinson and Company	10/16/2025	Reiterated Rating	$181.85	$211.00	Sector Perform
ZBH Zimmer Biomet	10/10/2025	Set Price Target	$95.63	$111.00
JNJ Johnson & Johnson	10/10/2025	Reiterated Rating	$190.65	$209.00	Outperform
INSP Inspire Medical Systems	10/10/2025	Reiterated Rating	$76.21	$150.00	Outperform
PODD Insulet	10/10/2025	Boost Price Target	$322.33	$365.00	Outperform
BSX Boston Scientific	9/29/2025	Reiterated Rating	$97.29	$125.00	Outperform
BDX Becton, Dickinson and Company	9/25/2025	Initiated Coverage	$185.92	$211.00	Sector Perform
BDX Becton, Dickinson and Company	9/24/2025	Upgrade	$180.86		Hold
OM Outset Medical	8/19/2025	Reiterated Rating	$13.75	$22.00	Sector Perform
ISRG Intuitive Surgical	8/19/2025	Reiterated Rating	$484.30	$615.00	Outperform
PODD Insulet	8/8/2025	Boost Price Target	$308.12	$350.00	Outperform
ZBH Zimmer Biomet	8/8/2025	Boost Price Target	$98.61	$115.00	Outperform
TNDM Tandem Diabetes Care	8/7/2025	Lower Price Target	$10.83	$25.00	Outperform
OM Outset Medical	8/7/2025	Boost Price Target	$14.53	$22.00	Sector Perform
INSP Inspire Medical Systems	8/5/2025	Lower Price Target	$81.13	$180.00	Outperform
TFX Teleflex	8/1/2025	Boost Price Target	$114.60	$135.00	Sector Perform
PEN Penumbra	7/30/2025	Lower Price Target	$255.54	$325.00	Outperform
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$78.38	$89.00	Outperform
ISRG Intuitive Surgical	7/23/2025	Boost Price Target	$503.64	$615.00	Outperform
JNJ Johnson & Johnson	7/17/2025	Boost Price Target	$163.00	$185.00	Outperform
ZYXI Zynex	7/15/2025	Lower Price Target	$2.18	$3.00	Sector Perform
TFX Teleflex	7/15/2025	Set Price Target	$115.48	$130.00	Sector Perform
ABT Abbott Laboratories	7/15/2025	Boost Price Target	$130.89	$147.00	Outperform
JNJ Johnson & Johnson	6/5/2025	Reiterated Rating	$153.24	$181.00	Outperform
MDT Medtronic	5/22/2025	Lower Price Target	$81.39	$101.00	Outperform
OM Outset Medical	5/21/2025	Reiterated Rating	$19.30	$21.00	Sector Perform
OM Outset Medical	5/8/2025	Boost Price Target	$15.58	$14.00	Sector Perform
ZBH Zimmer Biomet	5/6/2025	Lower Price Target	$91.47	$112.00	Outperform
PEN Penumbra	4/24/2025	Boost Price Target	$299.75	$330.00	Outperform
BSX Boston Scientific	4/24/2025	Boost Price Target	$101.51	$120.00	Outperform
ISRG Intuitive Surgical	4/23/2025	Lower Price Target	$494.30	$605.00	Outperform
ABT Abbott Laboratories	4/17/2025	Boost Price Target	$131.85	$145.00	Outperform
JNJ Johnson & Johnson	4/16/2025	Reiterated Rating	$154.80	$181.00	Outperform
PEN Penumbra	4/15/2025	Reiterated Rating	$270.96	$315.00	Outperform
INSP Inspire Medical Systems	4/15/2025	Lower Price Target	$147.78	$215.00	Outperform
JNJ Johnson & Johnson	4/2/2025	Reiterated Rating	$154.57	$181.00	Outperform
ZYXI Zynex	3/12/2025	Downgrade	$7.00	$5.50	Sector Perform
PODD Insulet	3/6/2025	Initiated Coverage	$270.81	$340.00	Outperform
PEN Penumbra	2/19/2025	Boost Price Target	$300.47	$313.00	Outperform
JNJ Johnson & Johnson	2/19/2025	Reiterated Rating	$157.04	$181.00	Outperform
EW Edwards Lifesciences	2/12/2025	Reiterated Rating	$75.23	$85.00	Outperform
INSP Inspire Medical Systems	2/11/2025	Reiterated Rating	$179.55	$260.00	Outperform
ZBH Zimmer Biomet	2/7/2025	Lower Price Target	$100.92	$125.00	Outperform
BSX Boston Scientific	2/6/2025	Boost Price Target	$105.27	$116.00	Outperform
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
SYK Stryker	1/29/2025	Boost Price Target	$389.90	$435.00	Outperform
JNJ Johnson & Johnson	1/23/2025	Reiterated Rating	$146.57	$181.00	Outperform
ABT Abbott Laboratories	1/21/2025	Reiterated Rating	$115.96	$135.00	Outperform
ISRG Intuitive Surgical	10/18/2024	Boost Price Target	$512.00	$555.00	Outperform

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.